Companies / Israel
Drug Exports Outperform Expectations
September 2006 | Five Year ForecastsThe pharmaceutical sector was a driving force behind a the growth in Israel's s export sector in H106. According to the Manufacturers Association of Israel, foreign drug sales rose 60% to reach a total of US$1.4bn, leading BMI to revise its export forecasts for the country. Whereas previously we estimated H106 sales would be US$1.09, a better than expected performance on the US market has resulted in a higher total.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
